Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

BMC Cancer

  • Home
  • BMC Cancer

No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study

Posted by By BCDSP October 16, 2015Posted inUncategorized
Journal: BMC Cancer Authors: Claudia Becker 1, Susan S Jick 2, Christoph R Meier 3 4 5, Michael Bodmer 6 NLM Citation: Becker C, Jick SS, Meier CR, Bodmer M. No evidence for a decreased risk of thyroid cancer…
Read More
  • @BCDSP_DRG on Twitter
Boston Collaborative Drug Surveillance Program

11 Muzzey Street | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
Fax: +1 (781) 862-1680
E-mail: bcdsp@bcdsp.org

Copyright 2025 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top